Medical Oncology

Aims & Scope

Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy.

It also provides state-of-the-art reviews on clinical and experimental therapies.

Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.5
2024	2.80

SJR (SCImago Journal Rank)

Year	Value
2024	0.916

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	95

Journal Rank

Year	Value
2024	5546

Journal Citation Indicator

Year	Value
2024	2761

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies

  Citation: 476

  Authors: Ezzeldin M., Abdelaziz

• High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation

  Citation: 459

  Authors: Chuan-Yong, Jian-An, Ying, Cheng, Xue-Guang

• Treatment Resistance of Solid Tumors

  Citation: 449

  Authors: Peter, Oliver, Michael

• Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation

  Citation: 428

  Authors: Ming-chun, Zhe, Lin, Qian-qian, Hai-yang, Feng, Li-ming, Lei-ming, Shu-sen

• Current status of enhanced recovery after surgery (ERAS) protocol in gastrointestinal surgery

  Citation: 236

  Authors: Michał, Judene, Jan, Alexandros, Piotr, Michał, Andrzej

• Long-term survival with metastatic cancer to the brain

  Citation: 231

  Authors: WA, HR, ES, KH

• The prognostic value of preoperative NLR, d-NLR, PLR and LMR for predicting clinical outcome in surgical colorectal cancer patients

  Citation: 230

  Authors: Hou-Qun, Qi-Wen, Bang-Shun, Yu-Qin, Feng, Hui-Ling, Jie, Xian, Shu-Kui

• Metformin and cancer: new applications for an old drug

  Citation: 225

  Authors: Taxiarchis V., Robert D.

• Steps in metastasis: an updated review

  Citation: 204

  Authors: Jamal, Keywan

• Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies

  Citation: 201

  Authors: Janice P., Paul, David, Robert A., Anna, Alexandra, Mizue, Andrew, Jay, Gary

---